CLSI POCT14-2020
$48.10
Point-of-Care Monitoring of Anticoagulation Therapy
Published By | Publication Date | Number of Pages |
CLSI | 2020-07-27 | 68 |
This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.